| Catalog No. | 
			TD-HF686016 | 
		
		
			| Species reactivity | 
			Human | 
		
		
			| Applications | 
			Research Grade Biosimilar | 
		
		
			| Host species | 
			Humanized | 
		
		
			| Isotype | 
			IgG1-kappa | 
		
		
			| Expression system | 
			Mammalian Cells | 
		
		
			| Species | 
			Human | 
		
		
			| Clonality | 
			Monoclonal | 
		
		
			| Target | 
			TNF-beta, TNFSF1, Tumor necrosis factor ligand superfamily member 1, LTA, Lymphotoxin-alpha, LT-alpha, TNFB | 
		
		
			| Endotoxin level | 
			Please contact with the lab for this information. | 
		
		
			| Purity | 
			>95% as determined by SDS-PAGE. | 
		
		
			| Purification | 
			Protein A/G purified from cell culture supernatant. | 
		
		
			| Accession | 
			P01374 | 
		
		
			| Form | 
			Liquid | 
		
		
			| Storage buffer | 
			0.01M PBS, pH 7.4. | 
		
		
			| Stability and Storage | 
			Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | 
		
		
			| Alternate Names | 
			MLTA3698A, PRO283698, RG7416, CAS: 1202526-59-7 | 
		
		
			| Background | 
			Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis. | 
		
		
			| Note | 
			For research use only. Not suitable for clinical or therapeutic use. |